Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded $115 Million in Grants from the Japanese Government

LUNAR-FLU collaboration with CSL Seqirus achieves additional $17.5 million development milestone

...
-Today at 09:06 am- MarketScreener

Related Keywords

China ,Meiji ,Hokkaido ,Japan ,Minamisoma ,Fukushima ,San Diego ,California ,United States ,Japanese ,Seika Pharma ,Joseph Payne ,Twitter ,Nasdaq ,Co Ltd ,Linkedin ,Arcturus Therapeutics Holdings Inc ,Mrna Technology ,Arcturus Therapeutics Holdings ,Good Manufacturing Practice ,Business Wire ,Minamisoma City ,Pad Chivukula ,Chief Scientific Officer ,Meiji Seika Pharma ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,